Breathe Well Live Well
|
Verona Pharma starts asthma drug Phase II trial
Pharmaceutical Business Review Verona Pharma has started a Phase II trial of its respiratory drug RPL554 to determine if the drug has sustained bronchodilator actions, and is safe when given daily to patients who are suffering from mild asthma. The company has also treated first … Verona Pharma starts new trial of lead drug |
View full post on asthma – Google News
 Stockopedia |
Verona Pharma Receives Positive Results For Asthma Treatment At Higher Doses
Daily Markets By Stockopedia on February 22, 2011 | More Posts By Stockopedia | Author's Website Verona Pharma (LON:VRP) , the AIM listed biotech company with a focus on developing treatments for chronic respiratory diseases such as asthma, has completed a … Verona Pharma announces positive results from mild asthma study |
View full post on asthma – Google News
|
Verona Pharma announces positive results from mild asthma study
Trading Markets (press release) Verona Pharma plc, a biotechnology company, has completed a successful trial of higher doses of its lead respiratory drug, RPL554, in patients with mild asthma. The randomized, blinded trial, with placebo control, took place in Leiden, The Netherlands, … |
View full post on asthma – Google News
|
Verona Initiates New RPL554 Clinical Trial in Asthma
InfoGrok This study is the first of two further trials with RPL554 in patients with allergic asthma. Based on the results, it will determine the dosage used in a … |
View full post on asthma – Google News
 Proactive Investors UK |
VERONA PHARMA PLC – New Higher Dose RPL554 Clinical Trial in Asthma
Trading Markets (press release) This study is the first of two further trials with RPL554 in patients with allergic asthma. Based on the results, it will determine the dosage used in a … Verona Pharma starts Asthma drug trial STOCKS NEWS UK-Verona gains positive update on key drug Verona Pharma up 20% on new drug trial |
View full post on asthma – Google News
Proactive Investors UK |
Verona Pharma starts Asthma drug trial
Proactive Investors UK Verona Pharma (LON:VRP) has begun a new clinical trial to evaluate higher dosing of its key asthma drug, RPL554. The trial will help Verona set the dosage … |
View full post on asthma – Google News